Genomic Vision SA
PAR:GV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Alternative Income REIT PLC
LSE:AIRE
|
UK |
|
Western Mining Co Ltd
SSE:601168
|
CN |
Genomic Vision SA
Other Items
Genomic Vision SA
Other Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Genomic Vision SA
PAR:GV
|
Other Items
-€147k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
|
Valneva SE
PAR:VLA
|
Other Items
€2.8m
|
CAGR 3-Years
118%
|
CAGR 5-Years
84%
|
CAGR 10-Years
N/A
|
|
|
G
|
Genfit SA
PAR:GNFT
|
Other Items
-€211k
|
CAGR 3-Years
83%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
N/A
|
|
|
Inventiva SA
PAR:IVA
|
Other Items
-€24.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-24%
|
CAGR 10-Years
N/A
|
|
|
DBV Technologies SA
PAR:DBV
|
Other Items
-$832k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-52%
|
CAGR 10-Years
0%
|
|
|
Abivax SA
PAR:ABVX
|
Other Items
€16.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
119%
|
CAGR 10-Years
112%
|
|
Genomic Vision SA
Glance View
Génomic Vision SA is a molecular diagnostics and technology company, which develops and commercializes research tools and tests for the early detection of cancers and genetic diseases. The company is headquartered in Bagneux, Ile-De-France. The company went IPO on 2014-04-02. The company develops and commercializes single-DNA molecule diagnostic tests and research tools for life sciences, cancer and genetic diseases. The firm uses the molecular combining technique for the direct visualization of single DNA molecules to detect quantitative and qualitative changes in the genome landscape and establish their contribution to pathology. The company develops its products and services in three main markets: the medical diagnostic market focusing on DNA diagnostics (cancer genomics, genetic diseases); the pharmaceutical research and development market in the fields of genomics, to develop tests that can help physicians identify how patients are likely to respond to targeted therapies (personalized medicine, pharmacogenomics, cancer cell proliferation); and the academic laboratories research market, providing molecular combining tools for academic research in the field of cancer genetics, cytogenetics and DNA replication.
See Also
What is Genomic Vision SA's Other Items?
Other Items
-147k
EUR
Based on the financial report for Jun 30, 2023, Genomic Vision SA's Other Items amounts to -147k EUR.
What is Genomic Vision SA's Other Items growth rate?
Other Items CAGR 5Y
-16%
